These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Daily evaluation of organ function during renal replacement therapy in intensive care unit patients with acute renal failure. Cappi SB; Sakr Y; Vincent JL J Crit Care; 2006 Jun; 21(2):179-83. PubMed ID: 16769463 [TBL] [Abstract][Full Text] [Related]
27. [Blood purification in chronic renal failure with severe liver disease]. Sudo M Nihon Rinsho; 1992 Jan; 50 Suppl():112-7. PubMed ID: 1578663 [No Abstract] [Full Text] [Related]
29. Past, present and future of end-stage renal disease therapy in the United States. Uribarri J Mt Sinai J Med; 1999 Jan; 66(1):14-9. PubMed ID: 9989100 [TBL] [Abstract][Full Text] [Related]
30. On-line filtration therapies: emerging horizons. Kooman JP; van der Sande FM; Beerenhout CM; Leunissen KM Blood Purif; 2006; 24(2):159-62. PubMed ID: 16340182 [No Abstract] [Full Text] [Related]
31. Continuous versus intermittent renal replacement therapy in the intensive care unit. Bellomo R; Ronco C Kidney Int Suppl; 1998 May; 66():S125-8. PubMed ID: 9573588 [No Abstract] [Full Text] [Related]
32. [Treatment of hypertension in dialysis patients and renal transplant recipients]. Małyszko J; Fryc J; Myśliwiec M Przegl Lek; 2005; 62(7):694-7. PubMed ID: 16463704 [TBL] [Abstract][Full Text] [Related]
33. Renal replacement therapy in the intensive care unit. Ghossein C; Grouper S; Soong W Int Anesthesiol Clin; 2009; 47(1):15-24. PubMed ID: 19131749 [No Abstract] [Full Text] [Related]
34. Continuous renal replacement therapy: evolution in technology and current nomenclature. Ronco C; Bellomo R Kidney Int Suppl; 1998 May; 66():S160-4. PubMed ID: 9573595 [TBL] [Abstract][Full Text] [Related]
35. End-stage renal disease in patients with Fabry disease. Obrador GT; Ojo A; Thadhani R J Am Soc Nephrol; 2002 Jun; 13 Suppl 2():S144-6. PubMed ID: 12068027 [No Abstract] [Full Text] [Related]
36. Highlights of the epidemiology of renal replacement therapy in Central and Eastern Europe. Rutkowski B Nephrol Dial Transplant; 2006 Jan; 21(1):4-10. PubMed ID: 16280373 [TBL] [Abstract][Full Text] [Related]
37. Is renal replacement therapy for all possible in developing countries? Aviles-Gomez R; Luquin-Arellano VH; Garcia-Garcia G; Ibarra-Hernandez M; Briseño-Renteria G Ethn Dis; 2006; 16(2 Suppl 2):S2-70-2. PubMed ID: 16774015 [TBL] [Abstract][Full Text] [Related]
38. [Active treatment of renal disease in Finland]. Stenman S; Grönhagen-Riska C Duodecim; 1995; 111(15):1497-504. PubMed ID: 9244706 [No Abstract] [Full Text] [Related]
40. The effect of lactate-buffered solutions on the acid-base status of patients with renal failure. Davenport A; Will EJ; Davison AM Nephrol Dial Transplant; 1989; 4(9):800-4. PubMed ID: 2516612 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]